An observational study in Human Papilloma Virus, sponsored by Tufts University. Completed. Open to female participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-04.
Sponsored by Tufts University · Observational
This study assessed the feasibility of implementing a one-month Twitter campaign to promote knowledge about the human papillomavirus (HPV) vaccine among low-income women living in public housing.
Investigators recruited a convenience sample (n=35) of women ages 18-26 years who resided in public housing in Massachusetts. Investigators assessed the feasibility and acceptability of the campaign. Online assessed changes in HPV knowledge, attitudes, and vaccine intentions before and after the campaign.
234 studies on the registry are indexed under Papilloma; 28 are open to participants now.
This study's enrollment of 48 is below the median of 188 across 64 observational studies indexed under Papilloma.
Browse Papilloma studies →Tufts University is the lead sponsor of 225 studies on the registry; 24 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 7 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women residing in public housing Ages18-26 years No history of cervical cancer
Inclusion Criteria:
English-speaking women Age18-26 years Residents of public housing in two Massachusetts cities
Twitter messages delivered over 1 month period
Behavioral: Twitter
Participants received a daily tweet over a period of one-month with educational messages about HPV vaccine and cervical cancer
Measure of Humanpapilloma VirusVaccine Knowledge
13 items that assess knowledge about HPV, the HPV vaccine, and cervical cancer; HPV and cervical cancer risk factors and HPV transmission. Score from 0-100% with higher scores indicating greater knowledge
Time frame: 3 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tufts University